294 related articles for article (PubMed ID: 30031888)
1. Proinflammatory cytokines and ageing of the cardiovascular-renal system.
Smykiewicz P; Segiet A; Keag M; Żera T
Mech Ageing Dev; 2018 Oct; 175():35-45. PubMed ID: 30031888
[TBL] [Abstract][Full Text] [Related]
2. Immune and inflammatory mechanisms mediate cardiovascular diseases from head to toe.
Libby P; Mallat Z; Weyand C
Cardiovasc Res; 2021 Nov; 117(13):2503-2505. PubMed ID: 34698765
[No Abstract] [Full Text] [Related]
3. The role of infiltrating immune cells in dysfunctional adipose tissue.
Guzik TJ; Skiba DS; Touyz RM; Harrison DG
Cardiovasc Res; 2017 Jul; 113(9):1009-1023. PubMed ID: 28838042
[TBL] [Abstract][Full Text] [Related]
4. Cytokines as therapeutic targets for cardio- and cerebrovascular diseases.
Liberale L; Ministrini S; Carbone F; Camici GG; Montecucco F
Basic Res Cardiol; 2021 Mar; 116(1):23. PubMed ID: 33770265
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein and ageing.
Tang Y; Fung E; Xu A; Lan HY
Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():9-14. PubMed ID: 28378496
[TBL] [Abstract][Full Text] [Related]
6. Ultrafine carbon particle mediated cardiovascular impairment of aged spontaneously hypertensive rats.
Upadhyay S; Stoeger T; George L; Schladweiler MC; Kodavanti U; Ganguly K; Schulz H
Part Fibre Toxicol; 2014 Sep; 11():36. PubMed ID: 25442699
[TBL] [Abstract][Full Text] [Related]
7. The Innate Immune System and Cardiovascular Disease in ESKD: Monocytes and Natural Killer Cells.
Dounousi E; Duni A; Naka KK; Vartholomatos G; Zoccali C
Curr Vasc Pharmacol; 2021; 19(1):63-76. PubMed ID: 32600233
[TBL] [Abstract][Full Text] [Related]
8. Immunometabolic function of cholesterol in cardiovascular disease and beyond.
Yvan-Charvet L; Bonacina F; Guinamard RR; Norata GD
Cardiovasc Res; 2019 Jul; 115(9):1393-1407. PubMed ID: 31095280
[TBL] [Abstract][Full Text] [Related]
9. Urotensin II: a cardiovascular and renal update.
Zoccali C; Mallamaci F
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):199-204. PubMed ID: 18277155
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and Vascular Ageing: From Telomeres to Novel Emerging Mechanisms.
Chiriacò M; Georgiopoulos G; Duranti E; Antonioli L; Puxeddu I; Nannipieri M; Rosada J; Blandizzi C; Taddei S; Virdis A; Masi S
High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):321-329. PubMed ID: 31325087
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases.
Damen MSMA; Popa CD; Netea MG; Dinarello CA; Joosten LAB
Atherosclerosis; 2017 Sep; 264():83-91. PubMed ID: 28716457
[TBL] [Abstract][Full Text] [Related]
12. Fuel for thought: immunometabolism is a paradigm shift in understanding immunity in cardiovascular disease.
Caligiuri G; Norata GD
Cardiovasc Res; 2019 Jul; 115(9):1383-1384. PubMed ID: 31199480
[No Abstract] [Full Text] [Related]
13. The heart of immunology: immune mechanisms in cardiovascular medicine.
Hansson GK
Cardiovasc Res; 2021 Nov; 117(13):e166-e168. PubMed ID: 34849629
[No Abstract] [Full Text] [Related]
14. [Proinflammatory cytokines in cardiovascular diseases as potential therapeutic target].
Bielecka-Dabrowa A; Wierzbicka M; Goch JH
Wiad Lek; 2007; 60(9-10):433-8. PubMed ID: 18350717
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment.
Lazúrová I; Tomáš Ľ
Clin Rev Allergy Immunol; 2017 Jun; 52(3):323-332. PubMed ID: 27342458
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease.
Chow BS; Allen TJ
Clin Sci (Lond); 2016 Aug; 130(15):1307-26. PubMed ID: 27358027
[TBL] [Abstract][Full Text] [Related]
17. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
[TBL] [Abstract][Full Text] [Related]
18. [Cytokines, metalloproteinases, neopterin and cardiovascular mortality among patients with chronic renal failure].
Kościów K; Małecki R; Adamiec R
Pol Merkur Lekarski; 2007 Jan; 22(127):54-7. PubMed ID: 17477092
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Markers in Cardiovascular Disease; Lessons Learned and Future Perspectives.
Patoulias D; Stavropoulos K; Imprialos K; Athyros V; Grassos H; Doumas M; Faselis C
Curr Vasc Pharmacol; 2021; 19(3):323-342. PubMed ID: 32188386
[TBL] [Abstract][Full Text] [Related]
20. Macrophage Biology in Cardiovascular Diseases.
Khoury MK; Yang H; Liu B
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):e77-e81. PubMed ID: 33054391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
